HEALTHPEAK PROPERTIES INC (DOC)
US42250P1030 - REIT
Taking everything into account, DOC scores 3 out of 10 in our fundamental rating. DOC was compared to 130 industry peers in the Diversified REITs industry. There are concerns on the financial health of DOC while its profitability can be described as average. DOC does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
DOC had positive earnings in the past year.
DOC had a positive operating cash flow in the past year.
Each year in the past 5 years DOC has been profitable.
Each year in the past 5 years DOC had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.55%, DOC is in the better half of the industry, outperforming 60.94% of the companies in the same industry.
With a decent Return On Equity value of 3.61%, DOC is doing good in the industry, outperforming 61.72% of the companies in the same industry.
DOC has a Return On Invested Capital of 2.53%. This is comparable to the rest of the industry: DOC outperforms 45.31% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DOC is in line with the industry average of 3.08%.
The 3 year average ROIC (2.14%) for DOC is below the current ROIC(2.53%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 3.61% | ||
| ROIC | 2.53% |
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
1.3 Margins
The Profit Margin of DOC (12.08%) is better than 60.94% of its industry peers.
DOC's Profit Margin has declined in the last couple of years.
DOC has a Operating Margin (22.99%) which is in line with its industry peers.
In the last couple of years the Operating Margin of DOC has declined.
DOC has a worse Gross Margin (64.69%) than 64.06% of its industry peers.
DOC's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.99% | ||
| PM (TTM) | 12.08% | ||
| GM | 64.69% |
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
2. Health
2.1 Basic Checks
DOC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
DOC has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for DOC has been increased compared to 5 years ago.
Compared to 1 year ago, DOC has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.54, we must say that DOC is in the distress zone and has some risk of bankruptcy.
DOC's Altman-Z score of 0.54 is in line compared to the rest of the industry. DOC outperforms 45.31% of its industry peers.
The Debt to FCF ratio of DOC is 18.44, which is on the high side as it means it would take DOC, 18.44 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 18.44, DOC is in the better half of the industry, outperforming 75.78% of the companies in the same industry.
A Debt/Equity ratio of 1.00 indicates that DOC is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 1.00, DOC perfoms like the industry average, outperforming 58.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | 18.44 | ||
| Altman-Z | 0.54 |
ROIC/WACC0.36
WACC6.96%
2.3 Liquidity
A Current Ratio of 0.15 indicates that DOC may have some problems paying its short term obligations.
DOC has a worse Current ratio (0.15) than 99.22% of its industry peers.
DOC has a Quick Ratio of 0.15. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
DOC's Quick ratio of 0.15 is on the low side compared to the rest of the industry. DOC is outperformed by 99.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.15 | ||
| Quick Ratio | 0.15 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.82% over the past year.
DOC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.07% yearly.
Looking at the last year, DOC shows a quite strong growth in Revenue. The Revenue has grown by 18.79% in the last year.
DOC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.86% yearly.
EPS 1Y (TTM)6.82%
EPS 3Y19.28%
EPS 5Y14.07%
EPS Q2Q%0%
Revenue 1Y (TTM)18.79%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%25.92%
3.2 Future
The Earnings Per Share is expected to decrease by -9.32% on average over the next years.
DOC is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -20.89% yearly.
EPS Next Y-31.69%
EPS Next 2Y-37.33%
EPS Next 3Y-21.19%
EPS Next 5Y-9.32%
Revenue Next Year23.17%
Revenue Next 2Y14.23%
Revenue Next 3Y10.7%
Revenue Next 5Y-20.89%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 42.81, the valuation of DOC can be described as expensive.
DOC's Price/Earnings ratio is in line with the industry average.
DOC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.73.
A Price/Forward Earnings ratio of 91.47 indicates a quite expensive valuation of DOC.
DOC's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, DOC is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.81 | ||
| Fwd PE | 91.47 |
4.2 Price Multiples
DOC's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DOC indicates a somewhat cheap valuation: DOC is cheaper than 65.63% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.23 | ||
| EV/EBITDA | 14.42 |
4.3 Compensation for Growth
DOC's earnings are expected to decrease with -21.19% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)3.04
EPS Next 2Y-37.33%
EPS Next 3Y-21.19%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.07%, DOC is a good candidate for dividend investing.
DOC's Dividend Yield is a higher than the industry average which is at 15.49.
DOC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.07% |
5.2 History
The dividend of DOC decreases each year by -4.01%.
DOC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-4.01%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
242.60% of the earnings are spent on dividend by DOC. This is not a sustainable payout ratio.
DOC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP242.6%
EPS Next 2Y-37.33%
EPS Next 3Y-21.19%
HEALTHPEAK PROPERTIES INC
NYSE:DOC (12/20/2024, 8:05:43 PM)
After market: 20.12 0 (0%)20.12
+0.36 (+1.82%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners93.19%
Inst Owner Change-3.86%
Ins Owners0.3%
Ins Owner Change-3.14%
Market Cap14.07B
Analysts80
Price Target25.91 (28.78%)
Short Float %1.63%
Short Ratio2.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.07% |
Dividend Growth(5Y)-4.01%
DP242.6%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)103.52%
Min EPS beat(2)76.02%
Max EPS beat(2)131.02%
EPS beat(4)3
Avg EPS beat(4)36.89%
Min EPS beat(4)-86.62%
Max EPS beat(4)131.02%
EPS beat(8)5
Avg EPS beat(8)29.65%
EPS beat(12)8
Avg EPS beat(12)61.54%
EPS beat(16)10
Avg EPS beat(16)46.24%
Revenue beat(2)2
Avg Revenue beat(2)2.46%
Min Revenue beat(2)1.94%
Max Revenue beat(2)2.98%
Revenue beat(4)3
Avg Revenue beat(4)3.04%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)7.87%
Revenue beat(8)5
Avg Revenue beat(8)-7.49%
Revenue beat(12)8
Avg Revenue beat(12)-4.75%
Revenue beat(16)12
Avg Revenue beat(16)53.65%
PT rev (1m)3.39%
PT rev (3m)7.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-63.51%
EPS NY rev (1m)8.21%
EPS NY rev (3m)5.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.81 | ||
| Fwd PE | 91.47 | ||
| P/S | 5.51 | ||
| P/FCF | 30.23 | ||
| P/OCF | 13.82 | ||
| P/B | 1.64 | ||
| P/tB | 1.84 | ||
| EV/EBITDA | 14.42 |
EPS(TTM)0.47
EY2.34%
EPS(NY)0.22
Fwd EY1.09%
FCF(TTM)0.67
FCFY3.31%
OCF(TTM)1.46
OCFY7.24%
SpS3.65
BVpS12.24
TBVpS10.96
PEG (NY)N/A
PEG (5Y)3.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 3.61% | ||
| ROCE | 3.2% | ||
| ROIC | 2.53% | ||
| ROICexc | 2.55% | ||
| ROICexgc | 2.82% | ||
| OM | 22.99% | ||
| PM (TTM) | 12.08% | ||
| GM | 64.69% | ||
| FCFM | 18.21% |
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
ROICexc(3y)2.16%
ROICexc(5y)1.9%
ROICexgc(3y)2.33%
ROICexgc(5y)2.05%
ROCE(3y)2.71%
ROCE(5y)2.39%
ROICexcg growth 3Y28.26%
ROICexcg growth 5Y4.6%
ROICexc growth 3Y28.51%
ROICexc growth 5Y3.28%
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
F-Score6
Asset Turnover0.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | 18.44 | ||
| Debt/EBITDA | 5.49 | ||
| Cap/Depr | 56.91% | ||
| Cap/Sales | 21.62% | ||
| Interest Coverage | 2.44 | ||
| Cash Conversion | 65.32% | ||
| Profit Quality | 150.76% | ||
| Current Ratio | 0.15 | ||
| Quick Ratio | 0.15 | ||
| Altman-Z | 0.54 |
F-Score6
WACC6.96%
ROIC/WACC0.36
Cap/Depr(3y)183.97%
Cap/Depr(5y)234.29%
Cap/Sales(3y)65.04%
Cap/Sales(5y)98.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.82%
EPS 3Y19.28%
EPS 5Y14.07%
EPS Q2Q%0%
EPS Next Y-31.69%
EPS Next 2Y-37.33%
EPS Next 3Y-21.19%
EPS Next 5Y-9.32%
Revenue 1Y (TTM)18.79%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%25.92%
Revenue Next Year23.17%
Revenue Next 2Y14.23%
Revenue Next 3Y10.7%
Revenue Next 5Y-20.89%
EBIT growth 1Y39.7%
EBIT growth 3Y27.09%
EBIT growth 5Y6.6%
EBIT Next Year250.22%
EBIT Next 3Y57.85%
EBIT Next 5Y35.9%
FCF growth 1Y185.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.01%
OCF growth 3Y8.03%
OCF growth 5Y2.41%